Anavex Life Sciences Corp. (NASDAQ:AVXL – Get Rating) has been given a consensus rating of “Buy” by the seven research firms that are currently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation and six have assigned a buy recommendation to the company. The average twelve-month price […]
Wall Street brokerages expect Anavex Life Sciences Corp. (NASDAQ:AVXL – Get Rating) to announce ($0.16) earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have made estimates for Anavex Life Sciences’ earnings. Anavex Life Sciences posted earnings of ($0.14) per share during the same quarter last year, which indicates […]